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ABSTRACT 
Results of meat product influence on the serum lipid profile of hyperlipidemic rats are presented. Meat product for specialized 
nutrition content porcine aortas and hearts in ratio 1:3. Thirty male Wistar rats (380 ±20 g) aged approximately 1 year were 
kept in conventional standard conditions; water and feed were available ad libitum. Animals were randomly divided in 3 
groups: group 1 – negative control (n=10); group 2 – positive control (n=10) and group 3 – experimental animals (n=10). 
Animals in group 2 and 3 were modeled an alimentary hyperlipidemia by adding cholesterol, fat and vitamin D2 into diet. 
After modeling, rats in group 2 were fed with standard chow, in group 3 – meat product (8g/kg b.w.) with standard chow. On 
the 42nd day serum lipid profile was investigated and immunoassay was carried out. It was found that the developed meat 
product given to the hyperlipidemic rats led to a decrease in the concentration of cholesterol, triglycerides and atherogenic 
fractions of lipoproteins by 31.8% (p <0.05), 28.2% and 2.4 times (p <0.05), respectively. Estimation of the concentration 
changes in apolipoproteins, forming lipoprotein particles, allowed to indirectly determining the main lipoprotein reduction 
that contributed to the total decrease in the atherogenic index of serum, which reached 41.3% (p <0.05). Previous proteomic 
study revealed the presence of a number of specific proteins and peptides in tissues of porcine aortas and heart. The hypothesis 
that tissue-specific proteins could decomposed into active peptides with antiatherogenic action is considered. 
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INTRODUCTION 
Modern technologies are actively implemented in the food 
industry, among which a special place is occupied by the 
functional and specialized products. Major number of 
publications highlights the results of studies aimed at the 
modification of the recipe by adding essential nutrients as 
well as ingredients of vegetable and animal origin in order 
to achieve a certain biological effect (Hui, 2012; Weiss et 
al., 2010). 
Meat is a functional system including protein, conjugated 
linoleic acid (CLA), minerals (iron, zinc and selenium), 
vitamins (B, E), glutathione, ubiquinone, lipoic acid etc. 
(Arihara, 2006; Arihara and Ohata, 2011). Nowadays, 
the functional properties of meat are associated with 
biologically active peptides, such as L-carnitine, carnosine, 
anserine, creatine, taurine etc. (Arihara, 2006; Udenigwe 
and Howard, 2013; Lafarga and Hayes, 2014). Moreover, 
meat proteome is a source of bioactive sequences possessed 
hypotensive, antioxidant, opioid, immunomodulatory, 
prebiotic, mineral-binding, cholesterol-lowering and 
antimicrobial activity (Bauchart et al., 2006; Ahhmed and 
Muguruma, 2010; Toldrá et al., 2012; Udenigwe and 
Howard, 2013; Lafarga and Hayes, 2014). 
During the last decade a special emphasis is paid on 
peptides, native contained in raw materials or formed during 
the enzymatic hydrolysis or food processing (Mine and 
Shahidi, 2006). Moreover, advanced methodological 
approaches, particularly proteomics, confirmed that 
proteome and peptidome of any tissue are formed by not 
only constitutive structural and functional proteins and 
peptides, but also are characterised by a number of specific 
molecules involved in maitance of normal physiological 
condition (Fagerberg et al., 2014). 
In this regard, the study of by-products as sources of 
bioactive sequences involved in normalization of the 
metabolic disorders is very relevant to the food industry as 
well as development specialized and functional products on 
their basis. 
 
Scientific hypothesis 
 Previously, authors revealed that introduction of native 
tissues of cattle and porcine hearts and the aortas into the 
diet of hyperlipidemic rats led to a significant decrease of 
total cholesterol, triglycerides and atherogenic fractions of 
lipoproteins in serum (Chernukha et al., 2014). Porcine 
tissues possessed the greatest efficiency. 
 Proteomic study revealed the presence a number of 
specific proteins in tissues of porcine aortas: apolipoprotein 
A-1 involved in the formation of high density lipoproteins, 
peroxiredoxin-1 (in mixture with transgelin) involved in the 
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suppression of oxidative stress, galectin-1 induced 
apoptosis of T-lymphocytes, a number of heat shock 
proteins as well as about 22 tissue-specific peptides with 
unknown function.  
 Fatty acid-binding protein and about 6 tissue-specific 
peptides with unknown function were detected in tissues of 
porcine heart. However, it was found that these bioactive 
substances are decomposed after sterilization process of the 
product, except fatty acid-binding protein and several 
peptides (Chernukha et al., 2016).  
 Therefore we hypothesized that tissue-specific proteins 
could decomposed into active peptides with similar 
biological action. This fact could make it possible to create 
a functional meat product based on porcine heart and aortas.  
 
MATERIAL AND METHODOLOGY 
  
Meat product production  
 Meat product for specialized nutrition was produced on 
ZAO "Yoshkar-Olinskiy Myasokombinat”. Porcine hearts 
were chopped with a particle size of 2-3 mm and salted for 
12 h. Porcine aortas were chopped with a particle size of 2-
3 mm and homogenized in cutter at 3000rpm for 2-3 min. 
Minced hearts with the juice were quantitatively transferred 
in the cutter and homogenized at 3000rpm for 6-8 min (ratio 
of aorta to hearts 1:3). Obtained mince was packed in cans 
of lamister and sterilized at 115 °C, a pressure of 0.23 MPa 
for 40 min. Meat product contained 17.53 ±0.95% protein, 
3.82 ±0.13% fat, 0.305 ±0.015% sodium chloride, and 2.35 
±0.25% starch. 
 
Animal experiments 
 Thirty male Wistar rats (380 ±20 g) aged approximately 1 
year were kept in conventional standard conditions; water 
and feed were available ad libitum. Animals were randomly 
divided in 3 groups: group 1 – negative control (n=10); 
group 2 – positive control (n=10) and group 3 – 
experimental animals (n=10). Animals in group 1 (negative 
control) got a standard chow (Labkorm, Russia) ad libitum 
during the experiment. Rat model of alimentary 
hyperlipidemia was developed by adding cholesterol (2.0-
10.0%) and fat (10.0 – 25.5%) to the standard diet and 
vitamin D2 injection per os (35,000 IU/kg b.w.). After 
modeling, rats in group 2 (positive control) were fed with 
standard chow, in group 3 – meat product (8g/kg b.w.) with 
standard chow. 
On the 42nd day rats were euthanized in VETtech camera 
according to the rules of the animal welfare, blood samples 
biochemical investigations were taken. 
 
Biochemical analysis 
Biochemical investigations were carried out on automatic 
analyzer BioChem FC-360 (HTI, USA) according to 
instructions applied to measurement kits (HTI, USA). Total 
cholesterol (TCL), triglyceride (TG), cholesterol low-
density lipoproteins (CL LDL) and cholesterol high-density 
lipoproteins (CL HDL) levels were measured in rat serum. 
Cholesterol non-LDL and non-HDL was calculated as the 
difference between TCL and CL LDL and HDL. 
Atherogenic index (AI) = (TCL - CL HDL)/ CL HDL. 
Immunoassay 
Evaluation of apolipoprotein A-1 (Apo A-1), apolipoprotein 
B-100 (Apo B-100), and apolipoprotein E (Apo E) levels in the 
serum were measured on ImmunoChem 2100 (HTI, USA) 
using the respective commercial ELISA kits, according to the 
respective instructions (Cloud-Clone Corp., China). 
 
Statisic analysis   
 STATISTICA 10.0 software was used in this study for the 
statistical analyses. Significant differences were tested by 
using two-way analysis of variance (ANOVA), followed by 
Duncan’s test. Differences with p-values less than 0.05 were 
considered as statistically significant. 
 
RESULTS AND DISCUSSION 
 Long-term consumption of a diet enriched with cholesterol 
and animal fats led to the increase of TCL and of 
atherogenic fractions of lipoproteins and TG in rat serum. 
On the 42nd day after the cancellation of proatherogenic diet 
the concentration of TCL and TG in rat serum of group 2 
exceeded the group 1 level by 35.8% (p <0.05) and 17.0% 
(p <0.05). Redistribution of lipoprotein fractions was also 
noticed: CL LDL cholesterol increased by 15.5% (p <0.05) 
as well as CL non-LDL and non-LDL by 2.3 fold (p <0.05) 
(Table 1). 
Introduction of meat product into rat diet (group 3) led to 
a decrease in the serum concentration of TCL (31.8%, p 
<0.05) and TG (by 28.2%, p <0.05) compared with group 2. 
Redistribution of lipoprotein fractions was also noticed: CL 
LDL cholesterol decreased by 21.6% (p <0.05) as well as 
CL non-LDL and non-LDL by 2.4 fold (p <0.05) (table 1). 
Elevation of athergenic lipoproteins rate in group 2 
resulted in a significant increase of AI by 59.5% compared 
to group 1, while in group 3 it reduced by 41.3% compared 
with group 2 (table.1). 
Apolipoprotein levels directly correlate with the 
concentration of lipoproteins circulating in the blood. Apo 
A-I is the major protein of HDL and provide HDL binding 
with receptor, but also detected in chylomicrons (minor).  
Apo B-100 is the main ligand of very low and middle 
density lipoproteins (VLDL, MDL) and LDL to 
corresponding receptor. Apo E is the protein part of 
chylomicrons, VLDL, MDL and HDL (minor) and also 
provides ligand-specific regulation of lipoprotein-receptor 
binding process responsible for cholesterol and cholesterol 
ether transfer from blood to internal organs and tissues, 
mostly in liver (Olofsson et al., 2007; Camejo et al., 2014). 
 It is interesting to note that a significant increase of Apo 
A-I by 36.5% (p <0.05) and 38.0% (p <0.05) was revealed 
in group 2 compared with group 1 and 3, while CL HDL 
between all groups was not significantly changed. On the 
contrary, changes in the content of Apo B-100 were not 
observed. However, the concentration of CL LDL in group 
3 was lower by 21.6% (p <0.05) than in group 2. 
 On the other hand, the content of APO E in group 2 was 
significantly increased by 53.2% (p <0.05), while in group 
3 decreased to group 1 level (Table 1). These changes 
correlated with a decrease in the concentration of CL non-
LDL and non-LDL, characterizing a content of atherogenic 
lipoproteins such as chylomicrons, VLDL and MDL. 
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Thus, despite of CL LDL reduction in group 3, there were 
no significant differences in the change of Apo B-100 
concentration between the experimental and control groups. 
Therefore this observation may be linked to an increase of 
MDL and VLDL, whereas the increased content of Apo A-
I in the serum of positive control animals may be correlated 
not only with increase of HDL, but also with elevated 
chylomicron content. The hypothesis is confirmed by the 
increase of Apo E in the serum of positive control rats. Apo 
E content is correlated with the level of chylomicrons, MDL 
and VLDL summarized in CL non-LDL and non-LDL, and 
TG, which were in positive control group by 2.3 times (p 
<0.05) and 28.2% higher than in group 1. 
According to scientific hypothesis mentioned above, 
identified tissue-specific proteins could be decomposed into 
active peptides with similar biological action or observed 
hypolipidemic effect could be linked with saved after 
sterilization tissue-specific peptides (Chernukha et al., 
2016). More of them were identified in porcine aorta. 
In two reference studies, authors investigated the 
influence of fractions containing target proteins and 
peptides in animal experiments. It was revealed that per os 
injection of low-molecular ultrafiltrate (Mw<30kDa) during 
only 14 days to hyperlipidemic Guinea pigs lead to total 
cholesterol content and atherogenic index reduction by 
44.1% and 43.7%, respectively, due to CL LDL and CL 
non-LDL and non-LDL levels decrease by 43.7% and 
79.5%, respectively. Moreover, such inflammatory markers 
as serum C-reactive protein (CRP) and vascular endothelial 
growth factor (VEGF) was also reduced by 34.0% and 
58.3% on average, respectively (Chernukha et al., 2015). 
CRP is knewn as an acute phase protein involved in general 
atherosclerosis inflammation by attracting monocytes into 
atherosclerotic plaques zone by binding to a specific 
receptor (Seidova 2005; Huang et al., 2014). VEGF is a 
key regulator of the formation of microvessels and also 
known as a factor of endothelium disfunction (Mangilova, 
2012; Swirski and Robbins, 2013). 
In second reference study authors revealed that per os 
injection of peptide ultrafiltrate (Mw<5kDa) during only 14 
days to hyperlipidemic rats mainly contributed to 
normalization of inflammation and demonstrated regulatory 
activity, while that per os injection of ultrafiltrate 
containing middle weight proteins (Mw=5-30kDa) lead to 
total cholesterol content and atherogenic index reduction by 
30.1% and 40.7%, respectively, due to CL non-LDL and 
non-LDL levels decrease by 66.9% (Kotenkova, 2017). 
Thus, in both two reference studies hypolipidemic effect 
was observed after 14 days of per os injection of fractions 
containing target substanses, while meat product 
introduction into diet of rats with hyperlipidemia lead to 
noticeable serum lipids reduction only on 42nd day. This fact 
could be explained by target protein breakdown into 
peptides with less residual biological activity. On the other 
hand, numerous publications also confirmed structural 
proteins as a good sourse of bioactive peptides, including 
peptides with lipid-lowering action (Bauchart et al., 2006; 
Ahhmed and Muguruma, 2010; Toldrá et al., 2012; 
Udenigwe and Howard, 2013; Lafarga and Hayes, 
2014). In this regard, heart tissue is enriced with muscle 
tissue proteins, while aorta – collagen and elastine, which 
are a source of GLY-PRO peptides with hypolipidemic 
action (Lyapina et al., 2015). Presumably, active peptides 
could be generated both during meat product processing and 
digestion processes.  
 
CONCLUSION 
 Developed meat product contributed to serum lipid level 
reduction in hyperlipidemic rats, mainly due to the decrease 
of chylomicrons and VLDL content, which is resulted in AI 
reduction by 41.3% (p <0.05). Despite on the 
decomposition of functional protein and peptides 
compounds after heat treatment process, a pronounced 
lipid-lowering effect of the developed product was noted. 
This effect can be linked with protein breakdown during 
meat product processing and digestion processes which 
occur on peptides with less residual biological activity.  
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